| Name | Title | Contact Details |
|---|---|---|
Bradford Newton |
Chief Information Officer | Profile |
Well Point is a Half Moon Bay, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Majestic Care is a company that provides community-based senior care throughout Indiana, Ohio, and Michigan. They specialize in clinical services based on local needs, including short-term rehabilitation, long-term care, and memory care.
Carbon Health is a modern, tech-enabled healthcare company transforming the primary care, urgent care, and virtual care experience. With a team of expert physicians, engineers, and designers, Carbon Health pushes the boundaries of medicine to deliver personal, accessible and high quality care. We aim to give patients connection to their medical records, quick access for immediate and ongoing healthcare needs, and a network of healthcare experts. We want patients to feel as though they have an advocate - like a doctor in their family. With a growing network of trusted clinics, and an end-to-end platform that supports ongoing care management and virtual appointments, Carbon Health ensures world-class care is affordable and always in reach.
Health Partners Plans is a health insurance organization serving more than 267,456 members in Southeastern Pennsylvania. Founded more than 30 years ago, Health Partners Plans offers Medicaid, Medicare and Children`s Health Insurance Program (CHIP) plans that include special benefits to improve the health and wellness of our members. We`re also committed to boosting the health of our community through outreach, education and events. Health Partners Plans is one of the few hospital-owned health maintenance organizations in the country. We continually develop new ways to encourage better health outcomes and have received national recognition for our innovations in managed care.
Synthetic Biologics, Inc. trades on the NYSE MKT, LLC under the symbol "SYN". The Company`s principal executive offices are located in Rockville, MD, and the finance and administrative office is located in Ann Arbor, MI. Synthetic Biologics, Inc. is a microbiome-focused, clinical-stage company developing therapeutics to protect the microbiome while targeting pathogen-specific diseases. The Company`s lead candidates in Phase 2 development include SYN-004 which is designed to protect the gut microbiome from the effects of certain commonly used intravenous (IV) antibiotics for the prevention of C. difficile infection and antibiotic-associated diarrhea (AAD), and SYN-010 which is intended to reduce the impact of methane producing organisms in the gut microbiome to treat the underlying cause of irritable bowel syndrome with constipation (IBS-C). In addition, the Company is developing a monoclonal antibody combination for the treatment of Pertussis, and a Phase 2 oral estriol drug for the treatment of relapsing-remitting multiple sclerosis (MS) and cognitive dysfunction in MS.